<i>Plasmodium berghei</i> EXP-1 interacts with host Apolipoprotein H during <i>Plasmodium</i> liver-stage development.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28137845.
- Also identified by DOI 10.1073/pnas.1606419114 and PMC identifier 5320984.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The first, obligatory replication phase of malaria parasite infections is characterized by rapid expansion and differentiation of single parasites in liver cells, resulting in the formation and release of thousands of invasive merozoites into the bloodstream. Hepatic <i>Plasmodium</i> development occurs inside a specialized membranous compartment termed the parasitophorous vacuole (PV). Here, we show that, during the parasite's hepatic replication, the C-terminal region of the parasitic PV membrane protein exported protein 1 (EXP-1) binds to host Apolipoprotein H (ApoH) and that this molecular interaction plays a pivotal role for successful <i>Plasmodium</i> liver-stage development. Expression of a truncated EXP-1 protein, missing the specific ApoH interaction site, or down-regulation of ApoH expression in either hepatic cells or mouse livers by RNA interference resulted in impaired intrahepatic development. Furthermore, infection of mice with sporozoites expressing a truncated version of EXP-1 resulted in both a significant reduction of liver burden and delayed blood-stage patency, leading to a disease outcome different from that generally induced by infection with wild-type parasites. This study identifies a host-parasite protein interaction during the hepatic stage of infection by <i>Plasmodium</i> parasites. The identification of such vital interactions may hold potential toward the development of novel malaria prevention strategies.
Medical subject headings
- Liver
- Malaria
- Membrane Proteins
- Plasmodium berghei
- Protozoan Proteins
- beta 2-Glycoprotein I